本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.20
+0.04001.27%
盤後3.200.00000.00%19:58 EDT
成交量:803.41萬
成交額:2,567.51萬
市值:17.12億
市盈率:-3.13
高:3.25
開:3.21
低:3.15
收:3.16
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:0.49
換手率:1.54%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:1.87
市盈率(LYR):-2.22

資料載入中...

2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]